Pyxis Oncology announces Phase 1/2 trials for PYX-201, combining it with KEYTRUDA® to treat advanced solid tumors. Pyxis Oncology, Inc. has announced the initiation of two significant clinical ...
These tables present gross rates in U.S.$ and do not reflect any commissions payable. “Pyxis Theta” is fixed on a time charter for 12 months +/- 30 days, at $22,000 per day. “Pyxis Karteria ...
The completion of the $3.0 million common share repurchase program demonstrates Pyxis Tankers' commitment to returning value to shareholders and potentially enhancing share price. Redemption of ...
I’m looking at you, Blackmagic Cinema Camera. The PYXIS 6K is their latest camera in a far less quirky and more user-friendly mid-sized box-style camera. Over two weeks of testing this camera across ...
Built for professional use, the Blackmagic Pyxis takes the proven HDR full-frame sensor from the Blackmagic Cinema Camera 6K and puts it in a box-style camera that can be configured to suit ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
An all-in-one custom firmware package for the Nintendo Switch, bringing together various essential tools and applications for a complete custom firmware experience. Sigpatch and prod.key files are NOT ...
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results